(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MÉTODOS E COMPOSTOS ÚTEIS NA SÍNTESE DE UM INIBIDOR DE AAK1

Em AnáliseInvention PatentPCT · US2023013840

Application data

Invention Patent MÉTODOS E COMPOSTOS ÚTEIS NA SÍNTESE DE UM INIBIDOR DE AAK1 de LEXICON PHARMACEUTICALS, INC. — IPC A61K 31/444
Invention Patent MÉTODOS E COMPOSTOS ÚTEIS NA SÍNTESE DE UM INIBIDOR DE AAK1 de LEXICON PHARMACEUTICALS, INC. — IPC A61K 31/444. Drawing published by the INPI in the Industrial Property Gazette.

Number

112024016034

Type

Invention Patent

Filing

02/24/2023

Publication

11/26/2024

PCT

US2023013840

Progress at the INPI

  1. Filing02/24/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 02/24/2023. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 11/26/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

LEXICON PHARMACEUTICALS, INC.

US

See this company's full portfolio

Inventors

J. Y. (pessoa física)

CN

M. Z. (pessoa física)

US

T. C. (pessoa física)

CN

W. W. (pessoa física)

US

X. Z. (pessoa física)

CN

Technical data

IPC Classification

Priority claims

US

63/315,504 · 03/01/2022

Abstract

MÉTODOS E COMPOSTOS ÚTEIS NA SÍNTESE DE UM INIBIDOR DE AAK1. A presente invenção refere-se a métodos para a síntese de (S)-1-((2',6-bis(difluorometil)-[2,4'-bipiridin]-5-il)óxi)-2,4-dimetilpentan-2-amina e sais do mesmo, bem como compostos úteis neste documento.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

11/26/2024

RPI 2812

Alteração de dados cadastrais

#1.1

08/13/2024

RPI 2797

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.